![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LivaNova Announces FDA Clearance of Mitral Annuloplasty Ring
LivaNova Announces FDA Clearance of Mitral Annuloplasty Ring
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
June 14, 2018
The FDA granted 510(k) clearance for LivaNova’s Memo 4D semi-rigid mitral annuloplasty ring and confirmed the device’s first implantation.
The Memo 4D now offers a broader range of ring sizes from 24 to 42mm, allowing a new patient population to be treated for mitral regurgitation.
The device provides a chordal guide to speed up procedure times, and its improved ring design can reduce the risk of systolic anterior motion.
Upcoming Events
-
21Oct